FRIDAY, June 14, 2024 (HealthDay News) — Taking a cutting-edge weight-loss drug could help extremely obese patients drop enough pounds to be eligible for bariatric surgery, a new study shows. Patients with extreme obesity — a BMI of 70 or more — are at higher risk of complications from surgeryContinue Reading
WEDNESDAY, June 11, 2024 (HealthDay News) — Folks trying to control their blood sugar levels might do best to work out in the evening, a new study suggests. Exercise performed between 6 p.m. and midnight appeared to be better at controlling blood sugar levels all day long, according to resultsContinue Reading
TUESDAY, June 11, 2024 (HealthDay News) — It’s tempting to binge-watch TV, but yet another study finds that when it comes to healthy aging, the less time on your sofa, the better. The study looked at 20 years of data on more than 45,000 people taking part in the Nurses’Continue Reading
TUESDAY, June 11, 2024 (HealthDay News) — Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements for good health, even if they’re eating less. A new set of nutritional recommendations are expected to help people remain healthy even as they shed unwanted pounds, researchers say.Continue Reading
MONDAY, June 10, 2024 (HealthDay News) — An experimental ‘supercharged’ form of popular GLP-1 weight-loss meds could help ease fatty liver disease, a new trial suggests. The drug under development, survodutide, helped up to 83% of patients gain real improvements in markers of fatty liver disease, a widespread and potentiallyContinue Reading
THURSDAY, June 6, 2024 (HealthDay News) — Despite recent concerns that taking Ozempic, Wegovy or other GLP-1 medications might be unsafe before a surgery, a new review has uncovered no such danger. The issue arose because weight-loss drugs slow gastric emptying. The thought was that food might linger in theContinue Reading
TUESDAY, June 4, 2024 (HealthDay News) — Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so. Researchers at Case Western Reserve University in Cleveland report that obese folks with drinking issues whoContinue Reading
MONDAY, June 3, 2024 (HealthDay News) — Ozempic and Wegovy appear to improve people’s sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests. The active ingredient in the weight-loss medications, semaglutide, also appears to affect the way that the tongue and brain respond to sweet tastes,Continue Reading
MONDAY, June 3, 2024 (HealthDay News) — Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says. Up to now, doctors have been cautious about prescribing semaglutide to patients with a history of pancreatitis, because they feared theContinue Reading
FRIDAY, May 24, 2024 (HealthDay News) — Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found. The drug significantly reduces the risk of severe kidney events, heart problems and death from any cause in patients whoContinue Reading